Amelanotic metastatic gastric malignant melanoma: a case report

Anticancer Drugs. 2022 Jan 1;33(1):e808-e812. doi: 10.1097/CAD.0000000000001227.

Abstract

Melanoma is a malignant form of cutaneous cancer with an increasing incidence since 1970s, accounting for nearly 75% of the death related to skin cancer especially in western countries. Highest recurrence and mortality were observed for the subtype with distal metastasis, demonstrating poor outcomes. However, high incidence of gastrointestinal metastasis of malignant melanoma is frequently misdiagnosed due to lack of specific clinical manifestations, especially for the rare observed cases presented amelanotic appearance, accounting for about 2% of all metastatic cases. In the present study, we reported a 36-year-old male patient, who was firstly diagnosed as gastric cancer, and then was confirmed as amelanotic melanoma metastasis by pathological examination, demonstrating positive for melanoma markers including Melan A, S-100, Hmb45 and CD79a. In conclusion, for the amelanotic neoplasm observed during gastroscopy in patients with melanoma history, pathological examination should be carried out to confirm the possibility of melanoma metastasis, providing evidences for the following treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Male
  • Melanoma, Amelanotic / pathology*
  • Skin Neoplasms / pathology*
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / secondary*